PSYCHEMEDICS CORP's ticker is PMD and the CUSIP is 744375205. A total of 34 filers reported holding PSYCHEMEDICS CORP in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $50 | – | 10 | +11.1% | 0.00% | – |
| Q4 2021 | $0 | – | 9 | -65.4% | 0.00% | – |
| Q3 2021 | $0 | – | 26 | -42.2% | 0.00% | – |
| Q2 2021 | $0 | – | 45 | +104.5% | 0.00% | – |
| Q1 2021 | $0 | -100.0% | 22 | -89.1% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 201 | -11.5% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 227 | +13.5% | 0.00% | – |
| Q1 2020 | $1,000 | -50.0% | 200 | 0.0% | 0.00% | – |
| Q4 2019 | $2,000 | +100.0% | 200 | +32.5% | 0.00% | – |
| Q3 2019 | $1,000 | 0.0% | 151 | +277.5% | 0.00% | – |
| Q1 2019 | $1,000 | -96.3% | 40 | -97.7% | 0.00% | – |
| Q4 2018 | $27,000 | -18.2% | 1,728 | -0.9% | 0.00% | – |
| Q3 2018 | $33,000 | +10.0% | 1,743 | +10.7% | 0.00% | – |
| Q2 2018 | $30,000 | -31.8% | 1,575 | -24.1% | 0.00% | – |
| Q1 2018 | $44,000 | +2.3% | 2,075 | 0.0% | 0.00% | – |
| Q4 2017 | $43,000 | +13.2% | 2,075 | 0.0% | 0.00% | – |
| Q3 2017 | $38,000 | -26.9% | 2,075 | 0.0% | 0.00% | – |
| Q2 2017 | $52,000 | +8.3% | 2,075 | -12.6% | 0.00% | – |
| Q1 2017 | $48,000 | -38.5% | 2,375 | -25.2% | 0.00% | – |
| Q4 2016 | $78,000 | -77.8% | 3,175 | -82.1% | 0.00% | – |
| Q3 2016 | $351,000 | +41.0% | 17,703 | -2.2% | 0.00% | – |
| Q2 2016 | $249,000 | -3.1% | 18,095 | -3.4% | 0.00% | – |
| Q1 2016 | $257,000 | +47.7% | 18,725 | +9.2% | 0.00% | – |
| Q4 2015 | $174,000 | -19.1% | 17,150 | -19.9% | 0.00% | – |
| Q3 2015 | $215,000 | -34.8% | 21,410 | -3.8% | 0.00% | – |
| Q2 2015 | $330,000 | +17.0% | 22,260 | +30.9% | 0.00% | – |
| Q1 2015 | $282,000 | +4.4% | 17,000 | -4.5% | 0.00% | – |
| Q4 2014 | $270,000 | +1.9% | 17,800 | -4.8% | 0.00% | – |
| Q3 2014 | $265,000 | +157.3% | 18,700 | +156.2% | 0.00% | – |
| Q2 2014 | $103,000 | – | 7,300 | +34661.9% | 0.00% | – |
| Q4 2013 | $0 | – | 21 | +425.0% | 0.00% | – |
| Q2 2013 | $0 | – | 4 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEALTH EFFECTS LLC | 40,001 | $276,000 | 0.13% |
| SANTA MONICA PARTNERS LP | 20,000 | $138,000 | 0.10% |
| Invenomic Capital Management LP | 135,631 | $769,000 | 0.08% |
| Cannell Capital | 78,306 | $540,000 | 0.08% |
| RBF Capital, LLC | 144,231 | $996,000 | 0.06% |
| CRAWFORD INVESTMENT COUNSEL INC | 266,502 | $1,839,000 | 0.04% |
| Ancora Advisors LLC | 80,728 | $557,000 | 0.01% |
| HighMark Wealth Management LLC | 2,039 | $14,000 | 0.01% |
| Renaissance Technologies | 341,422 | $2,356,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 34,618 | $240,000 | 0.00% |